M&RP Recent Publications
Below are links to articles recently published regarding measles and rubella (listed first) as well as for articles of interest for other immunization (listed further below.)
Measles and Rubella Citations, Fourth Quarter of 2024
- Never waste a measles outbreak.
-
Measles vaccine effectiveness in African children: a systematic review and meta-analysis.
Endalamaw D, Nibret E, Munshea A, Mekonnen F, Tadesse S, Zeru T, Tefera M, Yismaw G.
BMC Infect Dis. 2024 Nov 21;24(1):1330.
doi: 10.1186/s12879-024-10239-w.
-
Progress Toward Measles Elimination - Worldwide, 2000-2023.
Minta AA, Ferrari M, Antoni S, Lambert B, Sayi TS, Hsu CH, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Wimmer A, Bose AS, O’Connor P, Crowcroft NS.
MMWR Morb Mortal Wkly Rep. 2024 Nov 14;73(45):1036-1042.
doi: 10.15585/mmwr.mm7345a4.
-
Global measles cases up 20% in 2023.
Kirby T.
Lancet Infect Dis. 2025 Jan;25(1):e17.
doi: 10.1016/S1473-3099(24)00827-2.PMID: 39736272 No abstract available.
-
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations.
Zehrung D, Innis BL, Suwantika AA, Ameri M, Biellik R, Birchall JC, Cravioto A, Jarrahian C, Fairlie L, Goodson JL, Kochhar S, Kretsinger K, Morgan C, Mvundura M, Rathi N, Clarke E, Mistilis JJ, Uwamwezi MC, Giersing B, Hasso-Agopsowicz M.
Vaccines (Basel). 2024 Nov 6;12(11):1258.
doi: 10.3390/vaccines12111258.PMID: 39591161
-
Global challenges and solutions to achieving and sustaining measles and rubella elimination.
Crowcroft NS, Minta AA, Antoni S, Ho LL, Perea W, Mulders MN, Bose AS, Wallace A, Blanc DC, O’Connor PM.
Rev Panam Salud Publica. 2024 Dec 16;48:e90.
doi: 10.26633/RPSP.2024.90. eCollection 2024.
-
Epidemic risks of measles and rubella in China: a systematic review and meta-analysis.
Lin YT, Gao YX, Zhang Y, Cui AL, Wang HL, Zhu Z, Mao NY.
World J Pediatr. 2024 Dec;20(12):1223-1239.
doi: 10.1007/s12519-024-00859-2. Epub 2024 Dec 3.
-
Lessons from Recent Measles Post-Campaign Coverage Surveys Worldwide.
Danovaro-Holliday MC, Koh M, Steulet C, Rhoda DA, Trimner MK.
Vaccines (Basel). 2024 Nov 6;12(11):1257.
doi: 10.3390/vaccines12111257.PMID: 39591160
-
The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination.
Thompson KM.
Vaccines (Basel). 2024 Oct 25;12(11):1210.
doi: 10.3390/vaccines12111210.PMID: 39591113
-
Temporal, spatial, and methodological considerations in evaluating the viability of measles wastewater surveillance.
Chen W, Bibby K.
Sci Total Environ. 2024 Dec 21;959:178141.
doi: 10.1016/j.scitotenv.2024.178141.
-
Impact of Immunization Strategies on Rubella Incidence During Progress Toward Rubella Control and Elimination - China, 2004-2023.
Liu S, Xu X, Liu Q, Tang L, Wang X, Huang A, Li J, Xiu Y, Yang H, Wen N, Rodewald LE, Yin Z, Wang F.
China CDC Wkly. 2024 Dec 13;6(50):1319-1324.
doi: 10.46234/ccdcw2024.262.PMID: 39734787
-
Teaching Students to Effectively Evaluate Scientific Evidence and Advocate for Research in the Context of Autism Spectrum Disorder and the Neurodiversity Movement.
Jacques-Fricke BT.
Dev Biol. 2024 Dec 27:S0012-1606(24)00287-2.
doi: 10.1016/j.ydbio.2024.12.015. Online ahead of print.PMID: 39733922
-
Trend and forecast of measles disease, in East Gojjam Zone, Amhara Region, Northwest Ethiopia, 2023: a crossectional study.
Wudu H, Alemu C, Minalu W, Berelie H, Bantie D.
BMC Res Notes. 2024 Dec 24;17(1):383.
doi: 10.1186/s13104-024-07057-3.
-
Shorter incubation period in symptomatic measles patients who had no history of measles vaccination.
Tanaka H, Takahashi Y, Matsumoto S, Matsuyama M, Nakayama K, Kodaira H, Kubota Y, Kawakami J, Kurata T, Kanbayashi D, Motomura K.
Vaccine. 2024 Dec 22;45:126652.
doi: 10.1016/j.vaccine.2024.126652.
-
Low IgG Seroconversion among Persons Vaccinated against Measles, Republic of Congo.
Tanaka H, Takahashi Y, Matsumoto S, Matsuyama M, Nakayama K, Kodaira H, Kubota Y, Kawakami J, Kurata T, Kanbayashi D, Motomura K.
Vaccine. 2024 Dec 22;45:126652.
doi: 10.1016/j.vaccine.2024.126652.
-
Low IgG Seroconversion among Persons Vaccinated against Measles, Republic of Congo.
Mavoungou YVT, Gangoué LG, Koukouikila-Koussounda F, Nkoua CB, Mayengue PI, Kankou JM, Kiminou PC, Mahoukou P, Dossou-Yovo LR, Ahombo G, Niama FR.
Emerg Infect Dis. 2025 Jan;31(1):197-199.
doi: 10.3201/eid3101.240911.
-
Seroprevalence of Measles Antibodies Among Migrant Populations: A Systematic Review and Meta-Analysis.
Pradhan SK, Panda A, Debata I, Panda PS.
Cureus. 2024 Nov 22;16(11):e74243.
doi: 10.7759/cureus.74243. eCollection 2024 Nov.
-
Measles, mumps and rubella vaccination coverage in capitals and interior region municipalities of Northeast Brazil: a household survey in a cohort of children born in 2017 and 2018.
Maciel AMS, Ramos AN Jr, Ferreira AF, Silva TL, Domingues CMAS, Saavedra RDC, Barbosa JC, França AP, Kerr LRFS, Teixeira MDG, Moraes JC; ICV 2020 Group; Silva AID, Ramos AN Jr, França AP, Oliveira ANM, Boing AF, Domingues CMAS, Oliveira CS, Maciel ELN, Guibu IA, Mirabal IRB, Barbosa JC, Lima JC, Moraes JC, Luhm KR, Caetano KAA, Lima LHO, Antunes MBC, Teixeira MDG, Teixeira MDC, Borges MFSO, Queiroz RCS, Gurgel RQ, Barata RB, Azevedo RNC, Oliveira SMDVL, Teles SA, Gama SGND, Mengue SS, Simões TC, Nascimento V, Araújo WN.
Epidemiol Serv Saude. 2024 Dec 16;33(spe2):e20231296.
doi: 10.1590/S2237-96222024v33e20231296.especial2.en.
-
Dynamics of communication on measles vaccination on digital platforms in the Brazilian context: challenges and perspectives.
Silva MDPS, Gattás VL, Luna EJA.
Rev Inst Med Trop Sao Paulo. 2024 Dec 6;66:e68.
doi: 10.1590/S1678-9946202466068.
-
Uptake of Measles Second Dose Vaccine and Its Associated Factors Among Children Age 24-35 Months in Merhabete Woreda, Ethiopia: 2022: A Cross-Sectional Study.
Wmeskel AM, Zergaw MW, Abocherugn HG.
Health Sci Rep. 2024 Dec 17;7(12):e70278.
doi: 10.1002/hsr2.70278. eCollection 2024 Dec.
-
[Successes and challenges in achieving and sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Americas, 2013-2023Conquistas e desafios para alcancar e manter a eliminacao do sarampo, da rubeola e da sindrome da rubeola congenita na Regiao das Americas, 2013-2023].
Pastor D, Bravo-Alcántara P, Durón R, Tirso CP, Ortiz C, Rey-Benito G.
Rev Panam Salud Publica. 2024 Dec 18;48:e140.
doi: 10.26633/RPSP.2024.140. eCollection 2024.
-
Monitoring measles infections using flight passenger dynamics in Europe: A data-driven approach.
Romano C, Branda F, Scarpa F, Lasinio GJ, Ciccozzi M.
Sci Data. 2024 Dec 18;11(1):1358.
doi: 10.1038/s41597-024-04231-x.
-
[High-quality Follow-up Measles and Rubella vaccination Campaign in Mexico, 2021Campanha de vacinacao de seguimento de alta qualidade contra sarampo e rubeola no Mexico, 2021].
Díaz-Ortega JL, Durón-Andino R, Zuñiga-Ocampo CO, Rios-Castillo JG, Román-Castro E, González-Ramírez LH, Aguilar-Villaseñor JM, Jacobo-Ramírez MG.
Rev Panam Salud Publica. 2024 Dec 16;48:e111.
doi: 10.26633/RPSP.2024.111. eCollection 2024.
-
[Measles and Rubella IgG Seropositivity in the Post-elimination Era, Costa Rica, 2012-2023Soropositividade de IgG para os virus do sarampo e da rubeola na era pos-eliminacao, Costa Rica, 2012-2023].
Ruiz-González AI, Agüero-Zumbado A, Abarca-Gómez L, Duron R, Queiroz D, Soto-Garita C, Rey-Benito G.
Rev Panam Salud Publica. 2024 Dec 16;48:e81.
doi: 10.26633/RPSP.2024.81. eCollection 2024.
-
Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas.
Andrus JK, Santos JI, Evans Gilbert T, Siqueira M, Gentile A, Boshell J, Reef S.
Rev Panam Salud Publica. 2024 Dec 16;48:e93.
doi: 10.26633/RPSP.2024.93. eCollection 2024.
-
[Risk factors and control measures in measles outbreaks in countries of the Region of the Americas, 2017-2023Fatores de risco e medidas de controle em surtos de sarampo em paises da Regiao das Americas, 2017-2023].
Pastor D, Bravo-Alcántara P, Durón R, Tirso CP, Ortiz C, Rey-Benito G.
Rev Panam Salud Publica. 2024 Dec 16;48:e105.
doi: 10.26633/RPSP.2024.105. eCollection 2024.
-
Lessons for sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Caribbean.
Evans-Gilbert T, Broome K, Irons B, Lewis-Bell KN, Ferdinand E, Figueroa JP.
Rev Panam Salud Publica. 2024 Dec 16;48:e60.
doi: 10.26633/RPSP.2024.60. eCollection 2024
-
[Microplanning as a tool to strengthen the National Immunization Program in BrazilLa microplanificación como herramienta para fortalecer el Programa Nacional de Inmunizaciones en Brasil].
Araújo ACM, Nascimento LMD, da Silva TPR, de Melo FC, Lemos DRQ, Matozinhos FP, Fernandes EG.
Rev Panam Salud Publica. 2024 Dec 16;48:e68.
doi: 10.26633/RPSP.2024.68. eCollection 2024
-
[Challenges and strategies in the response to the measles outbreak during the COVID-19 Pandemic in Mexico, 25 Years after eliminationDesafios e estrategias na resposta ao surto de sarampo durante a pandemia de COVID-19 no Mexico, 25 anos pos-eliminacao].
Ceballos-Liceaga SE, Romualdo-Tello NM, Sánchez-Novoa P, Sosa Laso L, Carbajal Sandoval G, Cruz-Ramírez E, Landín-Martínez K, Leriche-Ramírez C, García-Lozano H, López Martínez I, García-Rodríguez G, López-Ridaura R, Díaz Ortega JL.
Rev Panam Salud Publica. 2024 Dec 16;48:e77.
doi: 10.26633/RPSP.2024.77. eCollection 2024.
-
[Comprehensive approach to the interruption of the measles outbreak in Venezuela, 2017-2019: lessons learnedAbordagem integral para a interrupcao do surto de sarampo na Venezuela, 2017-2019: licoes aprendidas].
Muro L, Castillo L, Rodríguez L, D’Angelo P, Porras N, García JM, Valderrama N, Rodriguez R, Villalobos N, Torres C, Villavicencio V.
Rev Panam Salud Publica. 2024 Dec 16;48:e75.
doi: 10.26633/RPSP.2024.75. eCollection 2024.
-
Economic burden of measles outbreaks: a cost-of-illness study in a middle-income country in the post-elimination era.
de Soárez PC, Rozman LM, Fonseca TS, Borsari PR, Percio J, Barrera LSG, Sartori AMC.
Rev Panam Salud Publica. 2024 Dec 16;48:e103.
doi: 10.26633/RPSP.2024.103.
-
[Use of standardized criteria to verify interruption of a measles outbreak in the Buenos Aires Metropolitan Area during the COVID-19 pandemicEncerramento do surto de sarampo na area metropolitana de Buenos Aires durante a pandemia de COVID-19 aplicando criterios padronizados].
Elbert G, López Yunes M, González Lebrero C, Rapaport S, Barrios RN, Pérez MF, Valenzuela M, Pérez L, Bruggesser F, Magariños M.
Rev Panam Salud Publica. 2024 Dec 16;48:e95.
doi: 10.26633/RPSP.2024.95. eCollection 2024
-
Modelling and stability analysis of the dynamics of measles with application to Ethiopian data.
Berhe HW, Gebremeskel AA, Atsbaha HA, Kefela YY, Asgedom AA, Woldegerima WA, Osman S, Kabareh L.
Heliyon. 2024 Jul 2;10(13):e33594.
doi: 10.1016/j.heliyon.2024.e33594. eCollection 2024 Jul 15
-
Epidemiological Characteristics of Measles-Mumps-Rubella in China's Mainland during 2014-2021.
Li Z, Deng L, Li J, Ren X, He G.
Biomed Environ Sci. 2024 Nov 20;37(11):1273-1282.
doi: 10.3967/bes2024.135.
-
Undernutrition and antibody response to measles, tetanus and Haemophilus Influenzae type b (Hib) vaccination in pre-school south African children: The VHEMBE birth cohort study.
Eskenazi B, Rauch S, Elsiwi B, Bornman R, Obida M, Brewer A, Ward BJ, Chevrier J.
Vaccine. 2024 Dec 7:126564.
doi: 10.1016/j.vaccine.2024.126564.
-
Multiplexed Detection, Partitioning, and Persistence of Wild-Type and Vaccine Strains of Measles, Mumps, and Rubella Viruses in Wastewater.
Wu J, Wang MX, Kalvapalle P, Nute M, Treangen TJ, Ensor K, Hopkins L, Poretsky R, Stadler LB.
Environ Sci Technol. 2024 Dec 17;58(50):21930-21941.
doi: 10.1021/acs.est.4c05344.
-
Rising measles outbreaks: A call to strengthen preventive efforts.
Razizadeh MH.
New Microbes New Infect. 2024 Nov 20;62:101539.
doi: 10.1016/j.nmni.2024.101539. eCollection 2024 Dec.
-
The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic.
Filimonovic J, Stosic M, Gazibara T, Dotlic J, Joksimovic B, Subaric A, Stevanovic J, Radulovic A, Mijovic B, Subaric L, Kovacevic M, Radulovic J, Antonijevic A, Milic M.
Vaccine. 2025 Jan 12;44:126576.
doi: 10.1016/j.vaccine.2024.126576. Epub 2024 Dec 5.
-
Measles and rubella seroprevalence in adults using residual blood samples from health facilities and household serosurveys in Palghar District, Maharashtra, India, 2018 - 2019.
Prosperi C, Hasan AZ, Winter AK, Chaaithanya IK, Salvi NR, Chauhan SL, Kulkarni RN, Lachyan A, Gawali P, Kapoor M, Bhatt V, Kaduskar O, Deshpande GR, Esteban I, Ramasamy S, Kumar VS, Truelove SA, Kumar MS, Thangaraj JWV, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murhekar MV.
Epidemiol Infect. 2024 Dec 6;152:e161.
doi: 10.1017/S0950268824001389.
-
Further analysis of determinants of Pentavalent and Measles immunizations dropouts among children under five years of age in Ethiopia from Mini-EDHS 2019.
Tolera M, Birhanu A, Regassa LD, Getachew T, Negash A, Jibro U, Deressa A, Abdurahman D, Motuma A, Gamachu M, Mohammed F, Balis B, Mussa I.BMC Health Serv Res. 2024 Dec 2;24(1):1527.
doi: 10.1186/s12913-024-11573-0.
-
The Epidemiology and Diagnosis of Measles: Special Aspects Relating to Low Incidence.
Matysiak-Klose D, Mankertz A, Holzmann H.
Dtsch Arztebl Int. 2024 Dec 27;(Forthcoming):arztebl.m2024.0211.
doi: 10.3238/arztebl.m2024.0211. Online ahead of print.
-
Postpartum Measles, Varicella, and Rubella Vaccination Rates in Serologically Non-Immune Mothers with Public Insurance at an Urban Tertiary Care Center.
Kwon D, Wang A, Park J, Gamboa S, Sue R, Bahl K, Linker AS, Aoun R, Abraham C.
J Health Care Poor Underserved. 2024;35(4):1284-1293.
doi: 10.1353/hpu.2024.a943990.PMID: 39584213
-
Surveillance and agnostic capture sequencing of samples from individuals with rash-associated illness in Mali indicates regional transmission of measles virus from West and Central Africa.
Kané F, Collins J, Koné A, Keita NY, Cisse I, Koné KM, Diallo D, Konate I, Dabitao DK, Diarra B, Sanogo I, Coulibaly TA, Diallo M, Keita D, Tangara CO, Diakité M, Dao S, Fouth-Tchos K, Aboulhab J, Neal A, Shaw-Saliba K, Lu XJ, Briese T, Lipkin WI, Guindo I, Chen RY, Wickiser JK, Doumbia S.
Infect Genet Evol. 2024 Dec;126:105691.
doi: 10.1016/j.meegid.2024.105691.
-
Mapping priority areas for measles surveillance: stratifying reintroduction and transmission risk in Rio de Janeiro, Brazil.
Dos Santos YT, Praça HL, San Pedro A, Reis LNM, Conceição PB, Gibson G.
Rev Panam Salud Publica. 2024 Nov 20;48:e123.
doi: 10.26633/RPSP.2024.123. eCollection 2024.
-
Measles surveillance data analysis and serological survey in Quzhou, China, 2014-2024: an assessment of progress toward measles elimination.
Gong X, Zheng W, Lai S, Yin Z.
Front Med (Lausanne). 2024 Nov 5;11:1492873.
doi: 10.3389/fmed.2024.1492873. eCollection 2024.
-
Analysis of Measles and Rubella Immunoglobulin G Titers in COVID-19 Patients.
Başbulut E, Bilgin M, Işler H, Şen A, Kılıç SS, Çubukçu
M.Risk Manag Healthc Policy. 2024 Nov 14;17:2789-2801.
doi: 10.2147/RMHP.S472872. eCollection 2024.
-
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India.
Prosperi C, Hasan AZ, Winter AK, Chaaithanya IK, Salvi NR, Sharma S, Bansal AK, Chauhan SL, Kulkarni RN, Lachyan A, Gawali P, Kapoor M, Shrivastava AK, Chonker SK, Bhatt V, Kaduskar O, Deshpande GR, Esteban I, Sabarinathan R, Saravana Kumar V, Truelove SA, Kumar MS, Thangaraj JWV, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murhekar MV.
Epidemiol Infect. 2024 Nov 18;152:e143.
doi: 10.1017/S0950268824001353.
-
Estimating the optimal age for infant measles vaccination.
Goult E, Barrero Guevara LA, Briga M, Domenech de Cellès M.
Nat Commun. 2024 Nov 15;15(1):9919.
doi: 10.1038/s41467-024-53415-x.
- Measles: Millions of children missed routine vaccination last year, WHO and CDC warn.
- Machine learning algorithms for prediction of measles one vaccination dropout among 12-23 months children in Ethiopia.
-
Pediatric Rash Illness Outbreak with Initial Positive Measles Immunoglobulin M Antibody Test Results - American Samoa, March-July 2023.
Stefanos R, Schatzman S, Wakeman B, Raines K, Radhakrishnan L, Filardo TD, Crooke SN, Bankamp B, Beard RS, Ng TFF, Marine RL, Tong S, Konrote A, Johansson AM, Ilimaleota AF, Nua MT, Kemble SK, Desmond E, Rota PA, Routh JA, Hancock WT, Sugerman DE, Anesi MS; American Samoa Response Group.
MMWR Morb Mortal Wkly Rep. 2024 Nov 14;73(45):1030-1035.
doi: 10.15585/mmwr.mm7345a3.
-
Trends of the second measles vaccine (MCV2) over time after its launch as part of routine immunization in Nigeria: a brief research report.
Sato R.
Front Public Health. 2024 Oct 28;12:1392996.
doi: 10.3389/fpubh.2024.1392996. eCollection 2024.
-
Securing long-term immunity: The possible necessity of supplementary measles vaccination.
Kalayci F, Yigit M, Gulhan B, Kanik Yuksek S, Kilic EK, Ince YE, Demircioglu Kalayci B, Yuzdemir HS, Ozkaya Parlakay A.
BMC Infect Dis. 2024 Nov 11;24(1):1274.
doi: 10.1186/s12879-024-10149-x.
-
Inequalities in measles immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Osborne A, Bai-Sesay AU, Sesay U, Tommy A, Bangura C, Ahinkorah BO.
BMC Infect Dis. 2024 Nov 11;24(1):1280.
doi: 10.1186/s12879-024-10088-7.
-
Detection of live attenuated measles virus in the respiratory tract following subcutaneous MMR Vaccination.
Watkins TA, Brockhurst JK, Germain G, Griffin DE, Foxman EF.
J Infect Dis. 2024 Nov 6:jiae537.
doi: 10.1093/infdis/jiae537.
-
Measles Outbreaks in the Republic of Congo: Epidemiology of Laboratory-Confirmed Cases Between 2019 and 2022.
Mavoungou YVT, Niama FR, Gangoué LG, Koukouikila-Koussounda F, Bayonne MB, Nkoua Badzi C, Gandza Gampouo LA, Kiminou PC, Biyama-Kimia P, Mahoukou P, Bongolo Loukabou NC, Kankou JM, Mayengue PI, Ahombo G.
Adv Virol. 2024 Oct 28;2024:8501027.
doi: 10.1155/2024/8501027. eCollection 2024.
-
Mass vaccination and educational attainment: Evidence from the 1967-68 Measles Eradication Campaign.
Barteska P, Dobkowitz S, Olkkola M, Rieser M.
J Health Econ. 2023 Oct 10;92:102828.
doi: 10.1016/j.jhealeco.2023.102828.
-
Crisis-Related Measles Outbreaks in Low-Income Countries and the Need for Increased Health Systems Resilience.
Ghammari F, Jalilian H.
Disaster Med Public Health Prep. 2024 Oct 28;18:e206.
doi: 10.1017/dmp.2024.132.
-
Acceptance of Rubella-Containing Vaccine and Factors Associated with Acceptance among Women of Reproductive Age in China: A Cross-Sectional Study.
Xu X, Liu S, Wang X, Huang A, Li J, Zhou Y, Wang L, Qin Y, Ma Y, An S, Liu J, Tang L, Yin Z, Wang F.
Vaccines (Basel). 2024 Oct 8;12(10):1153.
doi: 10.3390/vaccines12101153.
-
Trends of Diphtheria-Tetanus-Pertussis and Measles Vaccine Coverage Preceding and during the COVID-19 Pandemic: An Analysis of the WHO European Region from 2000 to 2022.
Maugeri A, Barchitta M, Cappuccio G, Favara G, Magnano San Lio R, Agodi A.
Vaccines (Basel). 2024 Oct 6;12(10):1145.
doi: 10.3390/vaccines12101145.
-
Progress towards Measles and Rubella Elimination in the South-East Asia Region-2013-2023.
Khanal S, Bura V, Sangal L, Sethi R, Dhongde D, Bahl SK.
Vaccines (Basel). 2024 Sep 25;12(10):1094.
doi: 10.3390/vaccines12101094.
-
Unwelcome return: analyzing the recent rise of measles cases in the United States.
Kumar S, Singh S, Bansal V, Gupta V, Jain R.
Proc (Bayl Univ Med Cent). 2024 Aug 21;37(6):958-962.
doi: 10.1080/08998280.2024.2384019. eCollection 2024.
-
Characteristics Associated With Measles, Mumps, and Rubella Coverage and Exemptions After a School Immunization Law Change in Washington, 2019-2020.
Moore T, Graff K, Bell TR.
J Sch Health. 2024 Nov;94(11):1031-1039.
doi: 10.1111/josh.13504.
-
Measles confirmed case in vaccinated patient: Role of the specific IgG avidity testing.
Pérez-Abeledo M, Martín F, Jiménez S, Sanz JC.
Enferm Infecc Microbiol Clin (Engl Ed). 2024 Nov;42(9):539-540.
doi: 10.1016/j.eimce.2024.05.013. Epub 2024 Oct 20.
-
Rubella epidemiology in Lesotho after vaccine introduction: a five-year review, 2018-2022.
Makhupane T, Habedi D.
BMC Public Health. 2024 Oct 18;24(1):2874.
doi: 10.1186/s12889-024-20081-z.
-
Measles in the emergency room: the enemy is still there.
Ena J.
Rev Clin Esp (Barc). 2024 Dec;224(10):650-651.
doi: 10.1016/j.rceng.2024.10.005. Epub 2024 Oct 16.
-
Estimating the proportion of health care workers susceptible to measles infection in a large university hospital in Milan, Italy, 2019-2023.
Rizzo A, Mendola M, Salari F, Lombardi A, Longo M, Giacomelli A, Carrer P, Gismondo MR.
J Med Virol. 2024 Oct;96(10):e70015.
doi: 10.1002/jmv.70015.
-
Predictors of measles-rubella vaccination status in the Savannah Region, Ghana: A cross-sectional study among caregivers of children aged 18-59 months.
Adjei MR, Sarfo KA, Azornu CK, Kwarteng PG, Osei-Sarpong F, Baafi JV, Asamoah B, Kubio C, Grobusch MP, Ohene SA.
Vaccine X. 2024 Sep 29;20:100567.
doi: 10.1016/j.jvacx.2024.100567. eCollection 2024 Oct.
-
A recent history of disease outbreaks in Kenya, 2007-2022: Findings from routine surveillance data.
Geteri F, Dawa J, Gachohi J, Kadivane S, Humwa F, Okunga E.
BMC Res Notes. 2024 Oct 15;17(1):309.
doi: 10.1186/s13104-024-06930-5.
-
High rates of hepatic involvement associated with new epidemic measles strains in Romania.
Niculae CM, Matoru RM, Brîndușe O, Ioniță AV, Gorea ME, Țîrlescu LG, Constantin RA, Moroti R, Hristea A.
J Med Virol. 2024 Oct;96(10):e70001.
doi: 10.1002/jmv.70001.
-
The Impact of Video-Based Educational Intervention on Parents' Decision to Uptake the Measles-Rubella (MR) Vaccine in Jordan.
Alsaqer K, Kawafha M, Al-Maghaireh D, Jallad ST, Sheyab H, Al Kofahi A, Saleh M.
Public Health Nurs. 2024 Oct 10.
doi: 10.1111/phn.13445.
-
Estimating the risk and spatial spread of measles in populations with high MMR uptake: Using school-household networks to understand the 2013 to 2014 outbreak in the Netherlands.
Munday JD, Atkins KE, Klinkenberg D, Meurs M, Fleur E, Hahné SJ, Wallinga J, Jan van Hoek A.
PLoS Med. 2024 Oct 8;21(10):e1004466.
doi: 10.1371/journal.pmed.1004466. eCollection 2024 Oct.
-
Elimination of endemic measles and rubella transmission in Oman.
K Patel P, Al-Rawahi B, Al-Farsi N, Al-Mahruqi S, Al-Busaidy A, Al-Abri S.
IJID Reg. 2024 Sep 5;13:100437.
doi: 10.1016/j.ijregi.2024.100437. eCollection 2024 Dec.
BIBLIOGRAPHY ON ROUTINE IMMUNIZATION, FOURTH QUARTER 2024
-
Enablers to high vaccination uptake among a disadvantaged minority population: a qualitative study of the Arab population of Israel.
Essa-Hadad J, Jansen DEMC, Vervoort JPM, Edelstein M.
Isr J Health Policy Res. 2024 Dec 5;13(1):71.
doi: 10.1186/s13584-024-00660-6.
-
Cost of integrated immunization campaigns in Nigeria and Sierra Leone: bottom-up costing studies.
Boonstoppel L, Moi F, Banks C, Sibeudu F, Obodoechi D, Borces K, Onwujekwe O, Brenzel L.
BMC Health Serv Res. 2024 Nov 1;24(1):1334.
doi: 10.1186/s12913-024-11809-z.
-
Routine Vaccination Coverage - Worldwide, 2023.
Jones CE, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, Nedelec Y, Wallace A, Sodha SV, Sugerman C.
MMWR Morb Mortal Wkly Rep. 2024 Oct 31;73(43):978-984.
doi: 10.15585/mmwr.mm7343a4.
-
Advancing Immunization in Africa: Overcoming Challenges to Achieve the 2030 Global Immunization Targets.
Okesanya OJ, Olatunji G, Olaleke NO, Mercy MO, Ilesanmi AO, Kayode HH, Manirambona E, Ahmed MM, Ukoaka BM, Lucero-Prisno Iii DE.
Adolesc Health Med Ther. 2024 Oct 19;15:83-91.
doi: 10.2147/AHMT.S494099. eCollection 2024.
-
Improving the timeliness and equity of preschool childhood vaccinations: Mixed methods evaluation of a quality improvement programme in primary care.
Marszalek M, Hawking MKD, Gutierrez A, Firman N, Wu J, Robson J, Smith K, Dostal I, Ahmed Z, Bedford H, Billington A, Dezateux C.
Vaccine. 2025 Jan 1;43(Pt 1):126522.
doi: 10.1016/j.vaccine.2024.126522. Epub 2024 Nov 16.
-
Multi-level determinants of timely routine childhood vaccinations in The Gambia: Findings from a nationwide analysis.
Wariri O, Utazi CE, Okomo U, Dotse-Gborgbortsi W, Sogur M, Fofana S, Murray KA, Grundy C, Kampmann B.
Vaccine. 2025 Jan 1;43(Pt 2):126500.
doi: 10.1016/j.vaccine.2024.126500. Epub 2024 Nov 2.
-
Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2023-24 School Year.
Seither R, Yusuf OB, Dramann D, Calhoun K, Mugerwa-Kasujja A, Knighton CL, Kriss JL, Miller R, Peacock G.
MMWR Morb Mortal Wkly Rep. 2024 Oct 17;73(41):925-932.
doi: 10.15585/mmwr.mm7341a3.
-
Development of a wastewater based infectious disease surveillance research system in South Korea.
Kim YT, Lee K, Lee H, Son B, Song M, Lee SH, Kwon M, Kim DS, Noh TH, Lee S, Kim YJ, Lee MK, Lee KR.
Sci Rep. 2024 Oct 19;14(1):24544.
doi: 10.1038/s41598-024-76614-4.
-
Modelling the spatial variability and uncertainty for under-vaccination and zero-dose children in fragile settings.
Alegana VA, Ticha JM, Mwenda JM, Katsande R, Gacic-Dobo M, Danovaro-Holliday MC, Shey CW, Akpaka KA, Kazembe LN, Impouma B.
Sci Rep. 2024 Oct 17;14(1):24405.
doi: 10.1038/s41598-024-74982-5.
-
Determinants of maternal adherence to child vaccination in Jordan: A cross-sectional study.
Ta’an WF, Al-Rashdan RA, Shatnawi RM, Ai-Zenati A, Williams B, Mukattash TL.
Sci Rep. 2024 Oct 20;14(1):24635.
doi: 10.1038/s41598-024-74183-0.
-
ΩUnveiling the dimension of regional disparities: Assessing the disruption of immunisation services by COVID-19 in Bangladesh.
Akter E, Sayeed A, Siddique AB, Ahamed B, Manna RM, Hossain L, Tanvir KM, Sanim MAI, Rahman MH, Chowdhury S, Ara T, Hossain MA, Haider MS, Jabeen S, Ameen S, Shomik MS, Ahmed A, Huicho L, Matijasevich A, Maiga A, Rahman AE, Akseer N, El Arifeen S, Hossain AT, Amouzou A.
J Glob Health. 2024 Oct 25;14:05028.
doi: 10.7189/jogh.14.05028.
-
Does a correlation exist between delayed vaccination and a decreased vaccine confidence?
Reverte V, Zornoza-Moreno M, Molina-Salas YE, Romera-Guirado FJ, Celdrán-Navarro MDC, Pérez-Martín JJ.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2419750.
doi: 10.1080/21645515.2024.2419750. Epub 2024 Oct 27.
-
Cost of integrated immunization campaigns in Nigeria and Sierra Leone: bottom-up costing studies.
Boonstoppel L, Moi F, Banks C, Sibeudu F, Obodoechi D, Borces K, Onwujekwe O, Brenzel L.
BMC Health Serv Res. 2024 Nov 1;24(1):1334.
doi: 10.1186/s12913-024-11809-z.
-
Does a correlation exist between delayed vaccination and a decreased vaccine confidence?
Reverte V, Zornoza-Moreno M, Molina-Salas YE, Romera-Guirado FJ, Celdrán-Navarro MDC, Pérez-Martín JJ.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2419750.
doi: 10.1080/21645515.2024.2419750. Epub 2024 Oct 27.
-
Social listening applied to tailor communication on immunization in the Republic of Moldova.
Timotin A, Paladi A, Mita V, Chihai V, Lozan O.
Eur J Public Health. 2024 Oct 28:ckae161.
doi: 10.1093/eurpub/ckae161.
-
Vaccination coverage and access among children and adult migrants and refugees in the Middle East and North African region: a systematic review and meta-analysis.
Bouaddi O, Seedat F, Hasaan Mohammed HE, Evangelidou S, Deal A, Requena-Méndez A, Khalis M, Hargreaves S; Middle East and North Africa Migrant Health Working Group.
EClinicalMedicine. 2024 Nov 22;78:102950.
doi: 10.1016/j.eclinm.2024.102950. eCollection 2024 Dec.
-
Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates.
Moghtaderi A, Callaghan T, Luo Q, Motta M, Tan TQ, Hillard L, Dor A, Portnoy A, Winter A, Black B.
Vaccine. 2024 Dec 17;45:126631.
doi: 10.1016/j.vaccine.2024.126631.
-
[Impact of the new intervention model to increase vaccination coverage in Paraguay, 2023Impacto de um novo modelo de ação para aumentar as coberturas vacinais no Paraguai, 2023].
Pérez Centurión VT, Cousirat L, Araya S, Benítez I, Villafañe M, León D, Ramírez L, Snead L, Rojas A, Monges P, Revolero D, Chamorro G, Cabello Á, Pastor D.
Rev Panam Salud Publica. 2024 Dec 16;48:e96.
doi: 10.26633/RPSP.2024.96. eCollection 2024
-
Spatial targeting and integration across vaccination, vitamin A and deworming programs throughout India 2019-21.
Rerolle F, Dey AK, Benmarhnia T, Arnold BF.
Int J Epidemiol. 2024 Oct 13;53(6):dyae160.
doi: 10.1093/ije/dyae160.PMID: 39657980
-
Essential programme on immunization in WHO South-East Asia: A five-decade journey of saving millions of lives & ending diseases.
Bura VK, Srivastava R, Chawla AK, Njambe TOE, Khanal S, Sangal L, Jha S, Bahl S.
Indian J Med Res. 2024 Sep&Oct;160(3&4):267-278.
doi: 10.25259/IJMR_1527_2024.
-
Adult vaccination in India: A rapid review of current status & implementation challenges.
Bhattacharyya A, Shahabuddin SM.
Indian J Med Res. 2024 Sep&Oct;160(3&4):279-292.
doi: 10.25259/IJMR_1521_2024
-
Maintaining Immunizations for Vaccine-Preventable Diseases in a Changing World.
Baidya A, Willens V, Wonodi C, Moss WJ.
Annu Rev Public Health. 2024 Dec 10.
doi: 10.1146/annurev-publhealth-071723-111427.
-
Inequalities in uptake of childhood vaccination in England, 2019-23: longitudinal study.
Flatt A, Vivancos R, French N, Quinn S, Ashton M, Decraene V, Hungerford D, Taylor-Robinson D.
BMJ. 2024 Dec 11;387:e079550.
doi: 10.1136/bmj-2024-079550.
-
Barriers to child vaccination: The role of international sanctions.
Ko J, Leung CK, Lee HF, Ming WK.SSM
Popul Health. 2024 Oct 30;28:101723.
doi: 10.1016/j.ssmph.2024.101723. eCollection 2024 Dec.
-
Trend of immunization & gap in vaccine doses as observed in National Family Health Survey rounds in India.
Kalia M, Sharma M, Rohilla R, Rana K.
Indian J Med Res. 2024 Sep&Oct;160(3&4):303-311.
doi: 10.25259/ijmr_1770_23.
-
Mapping changes in the utilization of childhood immunization over 5 years in a south Indian tertiary care hospital.
Mathew M, Sanathan SR, Sebastian J, Ravi MD, Joy T, Theempalangad RM, Gowda P.
Ther Adv Vaccines Immunother. 2024 Oct 29;12:25151355241287705.
doi: 10.1177/25151355241287705. eCollection 2024.
-
[Rapid vaccination monitoring and its impact on vaccination coverage for high-quality catch-up campaigns in the Dominican Republic, 2023Monitoramento das estratégias de vacinação e impacto nas coberturas de vacinação para campanhas de seguimento de alta qualidade na República Dominicana, 2023].
Vargas A, Mateo A, Bello Z, Rodríguez Y, Rocha Queiroz Lemos D, Durón Andino R, Anchayhua Y, Peguero M.
Rev Panam Salud Publica. 2024 Dec 16;48:e125.
doi: 10.26633/RPSP.2024.125. eCollection 2024
-
Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis.
Valeriani F, Protano C, Pozzoli A, Vitale K, Liguori F, Liguori G, Gallè F.
Vaccines (Basel). 2024 Nov 7;12(11):1260.
doi: 10.3390/vaccines12111260.
-
Exposure to Pollutants and Vaccines' Effectiveness: A Systematic Review.
Protano C, Valeriani F, Vitale K, Del Prete J, Liguori F, Liguori G, Gallè F.
Vaccines (Basel). 2024 Nov 3;12(11):1252.
doi: 10.3390/vaccines12111252.
-
A retrospective cohort study on predicting infants at a risk of defaulting routine immunization in Uganda using machine learning models.
Nantongo BA, Nabukenya J, Nabende P, Kamulegeya J.
JAMIA Open. 2024 Nov 29;7(4):ooae132.
doi: 10.1093/jamiaopen/ooae132. eCollection 2024 Dec
-
Post COVID-19 vaccination coverage recovery model.
Piano MGD, Russo M, Vassallo F, Buono P, Ciarambino T, Carbone C, Russo G.
Ital J Pediatr. 2024 Nov 25;50(1):252.
doi: 10.1186/s13052-024-01777-9
-
Improving the timeliness and equity of preschool childhood vaccinations: Mixed methods evaluation of a quality improvement programme in primary care.
Marszalek M, Hawking MKD, Gutierrez A, Firman N, Wu J, Robson J, Smith K, Dostal I, Ahmed Z, Bedford H, Billington A, Dezateux C.
Vaccine. 2025 Jan 1;43(Pt 1):126522.
doi: 10.1016/j.vaccine.2024.126522. Epub 2024 Nov 16.
-
Multi-level determinants of timely routine childhood vaccinations in The Gambia: Findings from a nationwide analysis.
Wariri O, Utazi CE, Okomo U, Dotse-Gborgbortsi W, Sogur M, Fofana S, Murray KA, Grundy C, Kampmann B.
Vaccine. 2025 Jan 1;43(Pt 2):126500.
doi: 10.1016/j.vaccine.2024.126500. Epub 2024 Nov 2.
-
Routine Vaccination Coverage - Worldwide, 2023.
Jones CE, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, Nedelec Y, Wallace A, Sodha SV, Sugerman C.
MMWR Morb Mortal Wkly Rep. 2024 Oct 31;73(43):978-984.
doi: 10.15585/mmwr.mm7343a4.
-
Small-area variation in child under-vaccination in India: a multilevel analysis of cross-sectional data from 36 states and Union Territories, 707 districts, and 22,349 small-area clusters.
Johri M, Rajpal S, Kim R, Subramanian SV.
Lancet Reg Health Southeast Asia. 2024 Nov 8;32:100504.
doi: 10.1016/j.lansea.2024.100504. eCollection 2025 Jan.
-
Myths and misinformation associated with vaccine incompleteness: A survey study.
Kallas-Silva L, Couto MT, Soares MEM, Ferreira-Silva SN, Avelino-Silva VI.
Patient Educ Couns. 2025 Feb;131:108556.
doi: 10.1016/j.pec.2024.108556. Epub 2024 Nov 18
Partnership Alliance
The mark 'CDC' is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC's logo and work with the Partnership is not connected to any fundraising aspect of the organization.
Follow Us
Prelude Version 2.3.2